000 01455 a2200409 4500
005 20250513102102.0
264 0 _c19961211
008 199612s 0 0 eng d
022 _a0091-2700
024 7 _a10.1002/j.1552-4604.1996.tb04183.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTroy, S M
245 0 0 _aPharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cFeb 1996
300 _a175-81 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents, Second-Generation
_xadverse effects
650 0 4 _aCyclohexanols
_xadverse effects
650 0 4 _aDesvenlafaxine Succinate
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aLithium
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
650 0 4 _aVenlafaxine Hydrochloride
700 1 _aParker, V D
700 1 _aHicks, D R
700 1 _aBoudino, F D
700 1 _aChiang, S T
773 0 _tJournal of clinical pharmacology
_gvol. 36
_gno. 2
_gp. 175-81
856 4 0 _uhttps://doi.org/10.1002/j.1552-4604.1996.tb04183.x
_zAvailable from publisher's website
999 _c8846559
_d8846559